Discover 2,314 paid clinical trials in Oceanside, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,314
A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris
for
Lichen Planopilaris
Location: Irvine CA, Phoenix AZ, Scottsdale AZ, Oakland CA,
Sponsor: Priovant Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07532603
Phase2, Phase3, Recruiting
Venetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, LonGEVity Trial
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Irvine CA, Long Beach CA, Duarte CA, Newnan GA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT07218510
Phase2, Recruiting
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
for
Non-small Cell Lung Cancer
Location: Irvine CA, Duarte CA, Phoenix AZ, Grand Junction CO,
Sponsor: Canadian Cancer Trials Group
Sex: All
Age: 18+
Code: NCT06686771
Phase3, Recruiting
Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
for
Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8,
Location: Irvine CA, Newport Beach CA, Corona CA,
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT07288034
Phase2, Recruiting
A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma Patients
for
Multiple Myeloma
Location: Irvine CA, Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT07225738
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
for
Non-small Cell Lung Cancer (NSCLC)
Location: Orange CA, Los Angeles CA, Boise ID, Austin TX,
Sponsor: Nuvation Bio Inc.
Sex: All
Age: 18+
Code: NCT07154706
Phase3, Recruiting
Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
for
AMI Cardiogenic Shock
Location: Orange CA, Torrance CA, Albuquerque NM, Portland OR,
Sponsor: Abiomed Inc.
Sex: All
Age: 18+
Code: NCT06964685
Recruiting
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
for
Carcinoma, Hepatocellular, Hepatocellular Cancer,
Location: Irvine CA, Orange CA, Los Angeles CA, Pasadena CA,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07227012
Phase1, Phase2, Recruiting
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Irvine CA, Duarte CA, Los Angeles CA, Phoenix AZ,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07258511
Phase3, Recruiting
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
for
Small Cell Lung Cancer, Small Cell Lung Cancer ( SCLC ),
Location: Irvine CA, Duarte CA, New Lenox IL, Hinsdale IL
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07476287
Phase2, Recruiting
AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors
for
Metastatic or Locally Advanced Solid Tumors With Microsatellite Instability-high (MSI-H) or Mismatched Repair Deficiency (dMMR),
Location: Irvine CA, Newport Beach CA, Irving TX, Zion IL,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07403721
Phase1, Recruiting
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Location: Irvine CA, Tucson AZ, Nampa ID, Meridian ID, Boise ID,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04840602
Phase2, Recruiting
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
for
Skin Lesion
Location: Irvine CA
Sponsor: University of California, Irvine
Sex: All
Age: 0+
Code: NCT01771718
Recruiting
A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
for
Non Small Cell Lung Cancer, Advanced Non Small Cell Lung Cancer,
Location: Irvine CA, Goodyear AZ, Temple TX, Houston TX,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07154290
Phase2, Recruiting
EndoPAT Device for Endothelial Dysfunction in ED
for
Erectile Dysfunction, Hypogonadism, Male,
Location: Newport Beach CA
Sponsor: University of California, Irvine
Sex: Male
Age: 18+
Code: NCT06720597
Recruiting
Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer
Location: Irvine CA, Duarte CA, Houston TX, Zion IL, Tucker GA,
Sponsor: Generate Biomedicines
Sex: All
Age: 18+
Code: NCT07484022
Phase1, Recruiting
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Location: Irvine CA, Orange CA, Los Angeles CA, Bakersfield CA,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: Male
Age: 18+
Code: NCT07200830
Phase3, Recruiting
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
for
Breast Cancer
Location: Fullerton CA, Los Angeles CA, Billings MT, Seattle WA,
Sponsor: Celcuity Inc
Sex: All
Age: 18+
Code: NCT06757634
Phase3, Recruiting
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
for
Breast Neoplasms
Location: Newport Beach CA, Cerritos CA, Los Angeles CA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT06926868
Phase2, Phase3, Recruiting
Adding a Live Biotherapeutic Product (CBM588) to Pembrolizumab for the Treatment of Renal Cell Cancer After Surgery